Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardsons syndrome

David R. Williams; Janice L. Holton; Catherine Strand; Alan Pittman; Rohan de Silva; Andrew J. Lees; Tamas Revesz
June 2007
Brain: A Journal of Neurology;Jun2007, Vol. 130 Issue 6, p1566
Academic Journal
Clinical syndromes associated with progressive supranuclear palsy-tau pathology now include progressive supranuclear palsy-parkinsonism (PSP-P), in addition to classic Richardsons syndrome (RS) and pure akinesia with gait freezing (PAGF). Although pathological heterogeneity of progressive supranuclear palsy (PSP) has also been established, attempts to correlate this with clinical findings have only rarely provided conclusive results. The aim of this study was to investigate whether regional variations in the types of tau lesions or differences in overall tau load may explain the clinical differences between the RS, PSP-P and PAGF. Quantitative tau pathology assessment was performed in 17 brain regions in 42 cases of pathologically diagnosed PSP (22 RS, 14 PSP-P and 6 PAGF). Neurofibrillary tangles, tufted astrocytes, coiled bodies and thread pathology were quantitated and a grading system was developed separately for each region. Using these grades the overall tau load was calculated in each case. To establish a simplified system for grading the severity of tau pathology, all data were explored to identify the minimum number of regions that satisfactorily summarized the overall tau severity. The subthalamic nucleus, substantia nigra and globus pallidus were consistently the regions most severely affected by tau pathology. The mean severity in all regions of the RS group was higher than in PSP-P and PAGF, and the overall tau load was significantly higher in RS than in PSP-P (P = 0.002). Using only the grade of coiled body + thread lesions in the substantia nigra, caudate and dentate nucleus, a reliable and repeatable 12-tiered grading system was established (PSP-tau score: 0, mild tau pathology, restricted distribution; >7, severe, widespread tau pathology). PSP-tau score was negatively correlated with disease duration (Spearmans rho −0.36, P = 0.028) and time from disease onset to first fall (Spearmans rho −0.49, P = 0.003). The PSP-tau score in PSP-P (median 3, range 0–5) was significantly lower than in RS (median 5, range 2–10, Mann–Whitney U, P < 0.001). The two cases carrying the tau-H2 protective allele had the two lowest PSP-tau scores. We have identified significant pathological differences between the major clinical syndromes associated with PSP-tau pathology and the restricted, mild tau pathology in PSP-P supports its clinical distinction from RS. The grading system we have developed provides an easy-to-use and sensitive tool for the morphological assessment of PSP-tau pathology and allows for consideration of the clinical diversity that is known to occur in PSP.


Related Articles

  • Contact dependent reproducible hypomania induced by deep brain stimulation in Parkinson's disease: clinical, anatomical and functional imaging study. Miguel Ulla // Journal of Neurology, Neurosurgery & Psychiatry;Jun2011, Vol. 82 Issue 6, p607 

    Hypomanic symptoms depending on anatomical location of contacts are reported in patients with Parkinson's disease (PD) treated by deep brain stimulation (DBS) of the subthalamic nucleus (STN). However, the underlying cortical and subcortical dysfunction is debated. In this study, five PD...

  • Progressive supranuclear palsy on Guam. Yamazaki, Mineo; Makifuchi, Takao; Kwang-Ming Chen; Mori, Osamu; Katayama, Yasuo; Takahashi, Hitoshi; Oyanagi, Kiyomitsu // Acta Neuropathologica;Nov2001, Vol. 102 Issue 5, p510 

    This is the first report demonstrating that progressive supranuclear palsy (PSP) exists on Guam. This 75-year-old Guamanian Chamorro patient with slight dementia and rigidity with restriction of ocular up gaze was diagnosed as parkinsonism-dementia complex (PDC) of Guam clinically. However,...

  • Parkinson's Is My Beat.  // Nieman Reports;Fall2015, Vol. 69 Issue 4, p7 

    A personal narrative is presented which explores the author's experiences of suffering from Parkinson's disease.

  • Updated guidelines for Parkinson's disease. ROSE, VERNA L. // American Family Physician;12/1/1998, Vol. 58 Issue 9, p2175 

    Provides information on the updated treatment guidelines for the management of patients with Parkinson's disease. Details on the guidelines; Information on updated treatment algorithms.

  • New Uses for an Old Diagnostic Test.  // USA Today Magazine;Feb99, Vol. 127 Issue 2645, p13 

    Presents information on the other uses of the diagnostic test for rating the severity of Parkinson's disease. Effectiveness of the test; How the test was developed; Benefits of detecting the disease early.

  • Accumulation of phosphorylated tyrosine hydroxylase into insoluble protein aggregates by inhibition of an ubiquitin—proteasome system in PC12D cells. Kawahata, Ichiro; Tokuoka, Hirofumi; Parvez, Hasan; Ichinose, Hiroshi // Journal of Neural Transmission;Dec2009, Vol. 116 Issue 12, p1571 

    Tyrosine hydroxylase (TH) is a rate-limiting enzyme for the biosynthesis of catecholamines including dopamine. The relationship between proteasomal dysfunction and the etiology of Parkinson’s disease has been suggested, but it is unknown if TH protein is affected by proteasomal...

  • The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family. Salvatore Spina; Martin R. Farlow; Frederick W. Unverzagt; David A. Kareken; Jill R. Murrell; Graham Fraser; Francine Epperson; R. Anthony Crowther; Maria G. Spillantini; Michel Goedert; Bernardino Ghetti // Brain: A Journal of Neurology;Jan2008, Vol. 131 Issue 1, p72 

    Multiple system tauopathy with presenile dementia (MSTD) is an inherited disease caused by a (g) to (a) transition at position +3 in intron 10 of Tau. It belongs to the spectrum of frontotemporal dementia and parkinsonism linked to chromosome 17 with mutations in Tau (FTDP-17T). Here we present...

  • Enduring involvement of tau, β-amyloid, α-synuclein, ubiquitin and TDP-43 pathology in the amyotrophic lateral sclerosis/parkinsonism—dementia complex of Guam (ALS/PDC). Miklossy, Judith; Steele, John C.; Sheng Yu; McCall, Sherman; Sandberg, Glenn; McGeer, Edith G.; McGeer, Patrick L. // Acta Neuropathologica;Dec2008, Vol. 116 Issue 6, p625 

    Guam ALS/PDC is a severe tangle forming disorder endemic to Guam with features overlapping such neurodegenerative disorders as Alzheimer disease (AD), Parkinson disease (PD), progressive supranuclear palsy (PSP), ALS, corticobasal degeneration (CBD) and pallido-ponto-nigral degeneration (PPND)....

  • Timed 10-Foot Walk as a Predictor of Incident Parkinson's Disease: The Honolulu-Asia Aging Study. De Luca, Jacqueline; Ross, G. Webster; Bell, Christina; Kaon Fong; Abbott, Robert; Petrovitch, Helen; White, Lon; Blanchette, Patricia; Masaki, Kamal // Hawaii Medical Journal;Sep2009, Vol. 68 Issue 8, p181 

    Background The timed 10-foot walk is used clinically to diagnose and monitor functional impairment. Case-control studies have shown slower walking speeds in patients with prevalent Parkinson's disease (PD). We examined whether walking time predicts 10-year incident PD in elderly...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics